Comprehensive coverage on the latest pharmaceutical regulatory update and industry activities in China.
Sorry, there is no matched result.
- 2021 China CDE Drug Evaluation Report
- Monthly Report: New Drug Approvals in China | June 2022
- China Kicks off the 7th Round of Volume-based Procurement (VBP) of Drugs
- China Emphasizes Rare Disease & Pediatric Drugs in Adjusting the 2022 National Reimbursement Drug List (NRDL)
- Licensing Deals Involving Chinese Pharma Companies in H1 2022